
Iannis Aifantis/LinkedIn
Sep 7, 2025, 04:45
Iannis Aifantis: The pre-T Cell Receptor as an Immunotherapy Target in T Cell Leukemia
Iannis Aifantis, Chairman of the Department of Pathology at NYU School of Medicine, shared a post on X:
“You can never forget your first love!!
It took me back almost 25 years but it was a lot of fun to write (together with Ali Rosen in the lab) this News and Views for the fantastic story by Maria Toribio and colleagues on the pre-TCR as an immunotherapy target in T cell leukemia.”
Title: The pre-T cell receptor as a tumor immunotherapy target in T cell leukemia
Authors: Aliza Rosen, Iannis Aifantis
Read The Full Article at Nature Immunology.
More Posts Featuring Iannis Aifantis.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 7, 2025, 04:42
Sep 7, 2025, 04:25
Sep 6, 2025, 21:28
Sep 6, 2025, 20:34
Sep 6, 2025, 20:20
Sep 6, 2025, 20:00